Edition:
India

Viking Therapeutics Inc (VKTX.OQ)

VKTX.OQ on NASDAQ Stock Exchange Capital Market

8.72USD
1:30am IST
Change (% chg)

$-0.10 (-1.13%)
Prev Close
$8.82
Open
$8.75
Day's High
$8.92
Day's Low
$8.58
Volume
410,312
Avg. Vol
861,276
52-wk High
$24.00
52-wk Low
$3.70

About

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the development of therapies for metabolic and endocrine disorders. The Company's clinical program, VK5211, is an orally available drug candidate, which is in Phase II clinical trial for acute rehabilitation following non-elective hip... (more)

Overall

Beta: 2.68
Market Cap(Mil.): $635.28
Shares Outstanding(Mil.): 72.03
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates